Company: CBLO
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001882781-25-000034
Chunk: 422

Company: C2 Blockchain, Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1A
Chunk 422
---
 on the OTC Markets Group, Inc.’s OTCID tier, which subjects it to volatility, illiquidity, and limited investor
interest.

Our
common stock is quoted on the OTC Markets Group, Inc.’s OTCID tier under the symbol “CBLO.” Securities traded on the
OTC market are often thinly traded, subject to extreme price fluctuations, and may not provide a liquid market for investors. As a result,
investors may have difficulty buying or selling our shares, and the market price of our common stock may not reflect its underlying value.

-
5 -

Table
of Contents

The
market price of our common stock may fluctuate significantly, and investors may lose all or part of their investment.

The
trading price of our common stock may be highly volatile and subject to wide fluctuations in response to numerous factors, including
operating results, changes in our business strategy, market conditions for blockchain and cryptocurrency companies, announcements by
competitors, regulatory developments, and general market sentiment. As a result, investors may experience substantial losses.

We
may issue additional shares of common stock or other securities in the future, which could dilute existing stockholders and adversely
affect the market price of our common stock.

We
may issue additional equity securities to raise capital, acquire assets, or for other purposes. Any such issuances may dilute the ownership
interests of existing stockholders and could depress the market price of our common stock.

Our
common stock is currently considered to be a “penny stock,” which could make it more difficult for investors to sell their
shares.

Because
our common stock trades on the OTC Markets Group, Inc.’s OTCID tier at prices below $5.00 per share, it is likely considered a
“penny stock” under SEC rules. Broker-dealers who recommend penny stocks must provide investors with a standardized risk
disclosure document, make a suitability determination for each purchaser, and obtain the purchaser’s written consent prior to executing
a transaction. These additional requirements may limit the willingness of broker-dealers to make a market in our stock or recommend it
to investors, which may reduce the liquidity and market price of our shares.

The
risks described in this report may not include all of the risks that we face, and you may lose some or all of your investment.

The
risks and uncertainties described in this report are not the only ones we face. Additional risks that are not currently known to us,
that we consider